{"id":"https://openalex.org/W4392631891","doi":"https://doi.org/10.1136/ijgc-2024-esgo.603","title":"261 Patient characteristics, treatment patterns and real-world effectiveness of niraparib in France: an ESME retrospective study in recurrent ovarian cancer patients treated with niraparib maintenance","display_name":"261 Patient characteristics, treatment patterns and real-world effectiveness of niraparib in France: an ESME retrospective study in recurrent ovarian cancer patients treated with niraparib maintenance","publication_year":2024,"publication_date":"2024-03-01","ids":{"openalex":"https://openalex.org/W4392631891","doi":"https://doi.org/10.1136/ijgc-2024-esgo.603"},"language":"en","primary_location":{"id":"doi:10.1136/ijgc-2024-esgo.603","doi":"https://doi.org/10.1136/ijgc-2024-esgo.603","is_oa":true,"landing_page_url":"https://doi.org/10.1136/ijgc-2024-esgo.603","pdf_url":null,"source":{"id":"https://openalex.org/S41026820","display_name":"International Journal of Gynecological Cancer","issn_l":"1048-891X","issn":["1048-891X","1525-1438"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Gynecological Cancer","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://doi.org/10.1136/ijgc-2024-esgo.603","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5006619822","display_name":"Laurence Gladieff","orcid":"https://orcid.org/0000-0002-6980-9719","observed_orcids":["https://orcid.org/0000-0002-6980-9719"]},"institutions":[{"id":"https://openalex.org/I4210098740","display_name":"Institut universitaire du cancer de Toulouse Oncopole","ror":"https://ror.org/014hxhm89","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017","https://openalex.org/I4210098740","https://openalex.org/I4210128666"]},{"id":"https://openalex.org/I4210128666","display_name":"Institut Claudius Regaud","ror":"https://ror.org/03pa87f90","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210128666"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Laurence Gladieff","raw_affiliation_strings":["Institut Claudius Regaud \u2013 IUCT Oncopole, Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut Claudius Regaud \u2013 IUCT Oncopole, Toulouse, France","institution_ids":["https://openalex.org/I4210098740","https://openalex.org/I4210128666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037621098","display_name":"P. Macouillard","orcid":"https://orcid.org/0000-0003-0110-2415","observed_orcids":["https://orcid.org/0000-0003-0110-2415"]},"institutions":[{"id":"https://openalex.org/I4210141925","display_name":"UniCancer Group","ror":"https://ror.org/04vhgtv41","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210141925"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Pauline Macouillard","raw_affiliation_strings":["Unicancer, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Unicancer, Paris, France","institution_ids":["https://openalex.org/I4210141925"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016602683","display_name":"Philippe Toussaint","orcid":"https://orcid.org/0000-0003-2839-1579","observed_orcids":["https://orcid.org/0000-0003-2839-1579"]},"institutions":[{"id":"https://openalex.org/I4210105738","display_name":"Centre L\u00e9on B\u00e9rard","ror":"https://ror.org/01cmnjq37","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210105738"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Philippe Toussaint","raw_affiliation_strings":["Centre L\u00e9on B\u00e9rard, Lyon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre L\u00e9on B\u00e9rard, Lyon, France","institution_ids":["https://openalex.org/I4210105738"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073440691","display_name":"Nadia El Mouaddin","orcid":"https://orcid.org/0000-0001-7822-6884","observed_orcids":["https://orcid.org/0000-0001-7822-6884"]},"institutions":[{"id":"https://openalex.org/I4210101023","display_name":"GlaxoSmithKline (France)","ror":"https://ror.org/00z1h3j87","country_code":"FR","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210101023"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Nadia El-Mouaddin","raw_affiliation_strings":["GSK, Rueil-Malmaison, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GSK, Rueil-Malmaison, France","institution_ids":["https://openalex.org/I4210101023"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009580835","display_name":"Virginie Jacquemin","orcid":"https://orcid.org/0000-0002-6438-3309","observed_orcids":["https://orcid.org/0000-0002-6438-3309"]},"institutions":[{"id":"https://openalex.org/I4210101023","display_name":"GlaxoSmithKline (France)","ror":"https://ror.org/00z1h3j87","country_code":"FR","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210101023"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Virginie Jacquemin","raw_affiliation_strings":["GSK, Rueil-Malmaison, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GSK, Rueil-Malmaison, France","institution_ids":["https://openalex.org/I4210101023"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Anne Fages","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210101023","display_name":"GlaxoSmithKline (France)","ror":"https://ror.org/00z1h3j87","country_code":"FR","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210101023"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Anne Fages","raw_affiliation_strings":["GSK, Rueil-Malmaison, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GSK, Rueil-Malmaison, France","institution_ids":["https://openalex.org/I4210101023"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008399319","display_name":"Ga\u00eblle Nachbaur","orcid":"https://orcid.org/0000-0001-5116-0723","observed_orcids":["https://orcid.org/0000-0001-5116-0723"]},"institutions":[{"id":"https://openalex.org/I4210101023","display_name":"GlaxoSmithKline (France)","ror":"https://ror.org/00z1h3j87","country_code":"FR","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210101023"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Ga\u00eblle Nachbaur","raw_affiliation_strings":["GSK, Rueil-Malmaison, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GSK, Rueil-Malmaison, France","institution_ids":["https://openalex.org/I4210101023"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045755661","display_name":"Sophie Gourgou","orcid":"https://orcid.org/0000-0002-6328-9839","observed_orcids":["https://orcid.org/0000-0002-6328-9839"]},"institutions":[{"id":"https://openalex.org/I4387154388","display_name":"Institut Regional du Cancer de Montpellier","ror":"https://ror.org/02693j602","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210141925","https://openalex.org/I4387154388"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Sophie Gourgou","raw_affiliation_strings":["Institut R\u00e9gional du Cancer, Montpellier, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut R\u00e9gional du Cancer, Montpellier, France","institution_ids":["https://openalex.org/I4387154388"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064960834","display_name":"Christophe Pomel","orcid":"https://orcid.org/0000-0003-3903-7321","observed_orcids":["https://orcid.org/0000-0003-3903-7321","https://orcid.org/0009-0008-6748-3445"]},"institutions":[{"id":"https://openalex.org/I4210124119","display_name":"Centre Jean Perrin","ror":"https://ror.org/02pwnhd33","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210124119"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Christophe Pomel","raw_affiliation_strings":["Centre Jean Perrin, Clermont-Ferrand, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre Jean Perrin, Clermont-Ferrand, France","institution_ids":["https://openalex.org/I4210124119"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035202401","display_name":"Pierre\u2010Emmanuel Colombo","orcid":"https://orcid.org/0000-0002-0697-109X","observed_orcids":["https://orcid.org/0000-0002-0697-109X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pierre-Emmanuel Colombo","raw_affiliation_strings":["Institut R\u00e9gional du Cancer, Montpelllier, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut R\u00e9gional du Cancer, Montpelllier, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060000954","display_name":"Lise Bosquet","orcid":"https://orcid.org/0000-0001-5100-9425","observed_orcids":["https://orcid.org/0000-0001-5100-9425"]},"institutions":[{"id":"https://openalex.org/I4210141925","display_name":"UniCancer Group","ror":"https://ror.org/04vhgtv41","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210141925"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Lise Bosquet","raw_affiliation_strings":["Unicancer, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Unicancer, Paris, France","institution_ids":["https://openalex.org/I4210141925"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5049445132","display_name":"Manuel Jorge Rodrigues","orcid":"https://orcid.org/0000-0002-5443-0802","observed_orcids":["https://orcid.org/0000-0002-5443-0802"]},"institutions":[{"id":"https://openalex.org/I80043","display_name":"Institut Curie","ror":"https://ror.org/04t0gwh46","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I80043"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Manuel Rodrigues","raw_affiliation_strings":["Institut Curie, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut Curie, Paris, France","institution_ids":["https://openalex.org/I80043"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":8,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3800,"currency":"USD","value_usd":3800},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"34","issue":null,"first_page":"A307","last_page":"A308"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/niraparib","display_name":"niraparib","score":0.9950000047683716},{"id":"https://openalex.org/keywords/parp-inhibitors","display_name":"PARP inhibitors","score":0.7760000228881836},{"id":"https://openalex.org/keywords/recurrent-ovarian-cancer","display_name":"recurrent ovarian cancer","score":0.9309999942779541},{"id":"https://openalex.org/keywords/maintenance-therapy","display_name":"maintenance therapy","score":0.7099999785423279},{"id":"https://openalex.org/keywords/platinum-sensitive-recurrent-ovarian-cancer","display_name":"platinum-sensitive recurrent ovarian cancer","score":0.7770000100135803},{"id":"https://openalex.org/keywords/serous-epithelial-ovarian-cancer","display_name":"serous epithelial ovarian cancer","score":0.8080000281333923},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.906000018119812},{"id":"https://openalex.org/keywords/treatment-patterns","display_name":"treatment patterns","score":0.734000027179718},{"id":"https://openalex.org/keywords/platinum-based-chemotherapy-response","display_name":"platinum-based chemotherapy response","score":0.6399999856948853},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.7799999713897705},{"id":"https://openalex.org/keywords/real-world-effectiveness","display_name":"real-world effectiveness","score":0.8809999823570251},{"id":"https://openalex.org/keywords/france","display_name":"France","score":0.5379999876022339},{"id":"https://openalex.org/keywords/brca-wild-type","display_name":"BRCA wild-type","score":0.5870000123977661},{"id":"https://openalex.org/keywords/treatment-initiation-timing","display_name":"treatment initiation timing","score":0.49000000953674316},{"id":"https://openalex.org/keywords/platinum-free-interval","display_name":"platinum-free interval","score":0.6259999871253967},{"id":"https://openalex.org/keywords/complete-response","display_name":"complete response","score":0.3199999928474426}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7066415548324585},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.610881507396698},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.5742154717445374},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.5638095736503601},{"id":"https://openalex.org/C150173356","wikidata":"https://www.wikidata.org/wiki/Q6144101","display_name":"Serous fluid","level":2,"score":0.528865396976471},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5270944833755493},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4966621994972229},{"id":"https://openalex.org/C146357865","wikidata":"https://www.wikidata.org/wiki/Q1123245","display_name":"Stage (stratigraphy)","level":2,"score":0.47383198142051697},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4490915536880493},{"id":"https://openalex.org/C187960798","wikidata":"https://www.wikidata.org/wiki/Q7631152","display_name":"Subgroup analysis","level":3,"score":0.4308880865573883},{"id":"https://openalex.org/C2780739268","wikidata":"https://www.wikidata.org/wiki/Q2112244","display_name":"Progression-free survival","level":3,"score":0.4284055233001709},{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.36137667298316956},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3542421758174896},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.32521599531173706},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.25081387162208557},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1136/ijgc-2024-esgo.603","doi":"https://doi.org/10.1136/ijgc-2024-esgo.603","is_oa":true,"landing_page_url":"https://doi.org/10.1136/ijgc-2024-esgo.603","pdf_url":null,"source":{"id":"https://openalex.org/S41026820","display_name":"International Journal of Gynecological Cancer","issn_l":"1048-891X","issn":["1048-891X","1525-1438"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Gynecological Cancer","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1136/ijgc-2024-esgo.603","doi":"https://doi.org/10.1136/ijgc-2024-esgo.603","is_oa":true,"landing_page_url":"https://doi.org/10.1136/ijgc-2024-esgo.603","pdf_url":null,"source":{"id":"https://openalex.org/S41026820","display_name":"International Journal of Gynecological Cancer","issn_l":"1048-891X","issn":["1048-891X","1525-1438"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Gynecological Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4399916961","https://openalex.org/W3112172532","https://openalex.org/W3205399537","https://openalex.org/W4312921557","https://openalex.org/W4312272651","https://openalex.org/W4406800062","https://openalex.org/W4322012262","https://openalex.org/W2890342236","https://openalex.org/W4286295704","https://openalex.org/W7138927101"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2024-03-11T00:00:00"}